Colgate-Palmolive
$89.86
▼ -1.58%
−$1.44
NYSE · Consumer Defensive · Household & Personal Products
· price updated 9h ago
CL · NYSE · Consumer Defensive · Household & Personal Products · price updated 9h ago
$89.86
▼ -1.58% · −$1.44 today
AI research · $89.86
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Needs attention · 11% above Sector avg
23.31x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
3.46x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
18.87x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
20.99x
Quality
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
45.6%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
267.4%
Debt / equity
Balance-sheet leverage
Needs attention · Among weakest in sector
13.88x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.03x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $73.06B | 36.1 | +5.2% | 44 | |
| $7.47B | 69.7 | +123.3% | 72 | |
| $4.44B | 18.1 | +16.7% | 72 | |
| $9.64B | 16.3 | +14.8% | 70 | |
| $5.28B | 17.2 | +17.9% | 68 |
US stock research
Colgate-Palmolive — US core universe (S&P 500 sourced). CL was -1.6% in the latest available session at $89.86. Its reported market value was $73.06B with a trailing P/E of 36.1. Latest reported revenue was $21.05B, changing +5.2% year over year, with $2.04B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.